
### [MONDO:0019724](http://purl.obolibrary.org/obo/MONDO_0019724)
**Label:** secondary glomerular disease

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0019439](http://purl.obolibrary.org/obo/MONDO_0019439) (AA amyloidosis), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0018589](http://purl.obolibrary.org/obo/MONDO_0018589) (AApoAIV amyloidosis), [MONDO:0018227](http://purl.obolibrary.org/obo/MONDO_0018227) (hypocomplementemic urticarial vasculitis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0019355](http://purl.obolibrary.org/obo/MONDO_0019355) (adult-onset Still disease), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0019991](http://purl.obolibrary.org/obo/MONDO_0019991) (immunotactoid glomerulopathy), [MONDO:0019990](http://purl.obolibrary.org/obo/MONDO_0019990) (non-amyloid fibrillary glomerulopathy), [MONDO:0019396](http://purl.obolibrary.org/obo/MONDO_0019396) (collagen type III glomerulopathy), [MONDO:0000498](http://purl.obolibrary.org/obo/MONDO_0000498) (arteritic anterior ischemic optic neuropathy), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0007601](http://purl.obolibrary.org/obo/MONDO_0007601) (familial Mediterranean fever, autosomal dominant), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0014629](http://purl.obolibrary.org/obo/MONDO_0014629) (autoimmune interstitial lung disease-arthritis syndrome), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0018613](http://purl.obolibrary.org/obo/MONDO_0018613) (AH amyloidosis), [MONDO:0019988](http://purl.obolibrary.org/obo/MONDO_0019988) (Pauci-immune glomerulonephritis with ANCA), [MONDO:0016356](http://purl.obolibrary.org/obo/MONDO_0016356) (diffuse cutaneous systemic sclerosis), [MONDO:0019989](http://purl.obolibrary.org/obo/MONDO_0019989) (Pauci-immune glomerulonephritis without ANCA), [MONDO:0016359](http://purl.obolibrary.org/obo/MONDO_0016359) (limited systemic sclerosis), [MONDO:0016358](http://purl.obolibrary.org/obo/MONDO_0016358) (limited cutaneous systemic sclerosis), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0019463](http://purl.obolibrary.org/obo/MONDO_0019463) (non-amyloid monoclonal immunoglobulin deposition disease), [MONDO:0009303](http://purl.obolibrary.org/obo/MONDO_0009303) (anti-glomerular basement membrane disease), [MONDO:0008538](http://purl.obolibrary.org/obo/MONDO_0008538) (temporal arteritis), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0007099](http://purl.obolibrary.org/obo/MONDO_0007099) (familial visceral amyloidosis), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0015943](http://purl.obolibrary.org/obo/MONDO_0015943) (eosinophilic granulomatosis with polyangiitis), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0013276](http://purl.obolibrary.org/obo/MONDO_0013276) (Reynolds syndrome), [MONDO:0019733](http://purl.obolibrary.org/obo/MONDO_0019733) (AFib amyloidosis), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0019731](http://purl.obolibrary.org/obo/MONDO_0019731) (AApoAI amyloidosis), [MONDO:0009572](http://purl.obolibrary.org/obo/MONDO_0009572) (autosomal recessive familial Mediterranean fever), [MONDO:0019732](http://purl.obolibrary.org/obo/MONDO_0019732) (ALys amyloidosis), [MONDO:0017991](http://purl.obolibrary.org/obo/MONDO_0017991) (Takayasu arteritis), [MONDO:0019730](http://purl.obolibrary.org/obo/MONDO_0019730) (light chain deposition disease), [MONDO:0018088](http://purl.obolibrary.org/obo/MONDO_0018088) (familial Mediterranean fever), [MONDO:0008889](http://purl.obolibrary.org/obo/MONDO_0008889) (thromboangiitis obliterans), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0016533](http://purl.obolibrary.org/obo/MONDO_0016533) (apolipoprotein A-II amyloidosis), [MONDO:0019725](http://purl.obolibrary.org/obo/MONDO_0019725) (pediatric systemic lupus erythematosus), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0019124](http://purl.obolibrary.org/obo/MONDO_0019124) (microscopic polyangiitis), [MONDO:0019641](http://purl.obolibrary.org/obo/MONDO_0019641) (pauci-immune glomerulonephritis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0018596](http://purl.obolibrary.org/obo/MONDO_0018596) (systemic polyarteritis nodosa), [MONDO:0019125](http://purl.obolibrary.org/obo/MONDO_0019125) (relapsing polychondritis), [MONDO:0018671](http://purl.obolibrary.org/obo/MONDO_0018671) (IgG4-related kidney disease), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0018594](http://purl.obolibrary.org/obo/MONDO_0018594) (secondary polyarteritis nodosa), [MONDO:0018595](http://purl.obolibrary.org/obo/MONDO_0018595) (single-organ polyarteritis nodosa), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0019167](http://purl.obolibrary.org/obo/MONDO_0019167) (immunoglobulin a vasculitis), [MONDO:0018592](http://purl.obolibrary.org/obo/MONDO_0018592) (cutaneous polyarteritis nodosa), [MONDO:0008633](http://purl.obolibrary.org/obo/MONDO_0008633) (Muckle-Wells syndrome), [MONDO:0018593](http://purl.obolibrary.org/obo/MONDO_0018593) (primary polyarteritis nodosa), [MONDO:0019170](http://purl.obolibrary.org/obo/MONDO_0019170) (polyarteritis nodosa), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0019728](http://purl.obolibrary.org/obo/MONDO_0019728) (heavy chain deposition disease), [MONDO:0019729](http://purl.obolibrary.org/obo/MONDO_0019729) (light and heavy chain deposition disease), [MONDO:0019726](http://purl.obolibrary.org/obo/MONDO_0019726) (type II mixed cryoglobulinemia), [MONDO:0019605](http://purl.obolibrary.org/obo/MONDO_0019605) (Immunotactoid or fibrillary glomerulopathy), [MONDO:0019727](http://purl.obolibrary.org/obo/MONDO_0019727) (mixed cryoglobulinemia type III), 

**Mapped go classes:** [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0002481](http://purl.obolibrary.org/obo/GO_0002481) (antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent), [GO:0048237](http://purl.obolibrary.org/obo/GO_0048237) (rough endoplasmic reticulum lumen), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0045646](http://purl.obolibrary.org/obo/GO_0045646) (regulation of erythrocyte differentiation), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0019885](http://purl.obolibrary.org/obo/GO_0019885) (antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0050713](http://purl.obolibrary.org/obo/GO_0050713) (negative regulation of interleukin-1 beta secretion), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0030663](http://purl.obolibrary.org/obo/GO_0030663) (COPI-coated vesicle membrane), [GO:0030300](http://purl.obolibrary.org/obo/GO_0030300) (regulation of intestinal cholesterol absorption), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:0016998](http://purl.obolibrary.org/obo/GO_0016998) (cell wall macromolecule catabolic process), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0030140](http://purl.obolibrary.org/obo/GO_0030140) (trans-Golgi network transport vesicle), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0042026](http://purl.obolibrary.org/obo/GO_0042026) (protein refolding), [GO:0002374](http://purl.obolibrary.org/obo/GO_0002374) (cytokine secretion involved in immune response), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005643](http://purl.obolibrary.org/obo/GO_0005643) (nuclear pore), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0006968](http://purl.obolibrary.org/obo/GO_0006968) (cellular defense response), [GO:0051258](http://purl.obolibrary.org/obo/GO_0051258) (protein polymerization), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:0005639](http://purl.obolibrary.org/obo/GO_0005639) (integral component of nuclear inner membrane), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0071281](http://purl.obolibrary.org/obo/GO_0071281) (cellular response to iron ion), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0003796](http://purl.obolibrary.org/obo/GO_0003796) (lysozyme activity), [GO:0005577](http://purl.obolibrary.org/obo/GO_0005577) (fibrinogen complex), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0031210](http://purl.obolibrary.org/obo/GO_0031210) (phosphatidylcholine binding), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:0050613](http://purl.obolibrary.org/obo/GO_0050613) (delta14-sterol reductase activity), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0030126](http://purl.obolibrary.org/obo/GO_0030126) (COPI vesicle coat), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0002474](http://purl.obolibrary.org/obo/GO_0002474) (antigen processing and presentation of peptide antigen via MHC class I), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0006826](http://purl.obolibrary.org/obo/GO_0006826) (iron ion transport), [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0019835](http://purl.obolibrary.org/obo/GO_0019835) (cytolysis), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0000137](http://purl.obolibrary.org/obo/GO_0000137) (Golgi cis cisterna), [GO:0005795](http://purl.obolibrary.org/obo/GO_0005795) (Golgi stack), [GO:0042612](http://purl.obolibrary.org/obo/GO_0042612) (MHC class I protein complex), [GO:0045723](http://purl.obolibrary.org/obo/GO_0045723) (positive regulation of fatty acid biosynthetic process), [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen), [GO:0002830](http://purl.obolibrary.org/obo/GO_0002830) (positive regulation of type 2 immune response), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0070087](http://purl.obolibrary.org/obo/GO_0070087) (chromo shadow domain binding), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0033216](http://purl.obolibrary.org/obo/GO_0033216) (ferric iron import), [GO:2000553](http://purl.obolibrary.org/obo/GO_2000553) (positive regulation of T-helper 2 cell cytokine production), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:0006890](http://purl.obolibrary.org/obo/GO_0006890) (retrograde vesicle-mediated transport, Golgi to ER), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006891](http://purl.obolibrary.org/obo/GO_0006891) (intra-Golgi vesicle-mediated transport), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0008035](http://purl.obolibrary.org/obo/GO_0008035) (high-density lipoprotein particle binding), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0042347](http://purl.obolibrary.org/obo/GO_0042347) (negative regulation of NF-kappaB import into nucleus), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0071283](http://purl.obolibrary.org/obo/GO_0071283) (cellular response to iron(III) ion), [GO:0072378](http://purl.obolibrary.org/obo/GO_0072378) (blood coagulation, fibrin clot formation), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:0002726](http://purl.obolibrary.org/obo/GO_0002726) (positive regulation of T cell cytokine production), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:2000321](http://purl.obolibrary.org/obo/GO_2000321) (positive regulation of T-helper 17 cell differentiation), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0001916](http://purl.obolibrary.org/obo/GO_0001916) (positive regulation of T cell mediated cytotoxicity), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0005652](http://purl.obolibrary.org/obo/GO_0005652) (nuclear lamina), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0032621](http://purl.obolibrary.org/obo/GO_0032621) (interleukin-18 production), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:1904440](http://purl.obolibrary.org/obo/GO_1904440) (positive regulation of ferrous iron import across plasma membrane), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0050829](http://purl.obolibrary.org/obo/GO_0050829) (defense response to Gram-negative bacterium), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0061702](http://purl.obolibrary.org/obo/GO_0061702) (inflammasome complex), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0044546](http://purl.obolibrary.org/obo/GO_0044546) (NLRP3 inflammasome complex assembly), [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding), [GO:0002674](http://purl.obolibrary.org/obo/GO_0002674) (negative regulation of acute inflammatory response), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071224](http://purl.obolibrary.org/obo/GO_0071224) (cellular response to peptidoglycan), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0030157](http://purl.obolibrary.org/obo/GO_0030157) (pancreatic juice secretion), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0050701](http://purl.obolibrary.org/obo/GO_0050701) (interleukin-1 secretion), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0032611](http://purl.obolibrary.org/obo/GO_0032611) (interleukin-1 beta production), [GO:0072559](http://purl.obolibrary.org/obo/GO_0072559) (NLRP3 inflammasome complex), 

**Class expressions from DL-Learner:**

- Thing 55.54%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.67%
- [GO:0048237](http://purl.obolibrary.org/obo/GO_0048237) (rough endoplasmic reticulum lumen) 50.67%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 50.67%
- [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen) 50.67%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.67%
- [GO:0005577](http://purl.obolibrary.org/obo/GO_0005577) (fibrinogen complex) 50.67%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.02%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 36.02%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.02%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 36.02%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 36.02%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005177](http://purl.obolibrary.org/obo/GO_0005177) (obsolete neuroligin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.02%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005162](http://purl.obolibrary.org/obo/GO_0005162) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.02%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005156](http://purl.obolibrary.org/obo/GO_0005156) (obsolete epidermal growth factor receptor inhibiting ligand activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.02%


